Tonix Pharmaceuticals Holding (TNXP) Other Non Operating Income (2012 - 2025)

Tonix Pharmaceuticals Holding's Other Non Operating Income history runs 4 years deep, the most recent figure standing at -$1.2 million for Q3 2025.

• On a quarterly basis, Other Non Operating Income changed N/A year-over-year to -$1.2 million in Q3 2025; TTM through Mar 2026 was -$1.2 million, a 45.11% increase from a year earlier, with the FY2025 full-year figure at -$2.1 million, changed N/A from the prior year.
• Other Non Operating Income climbed to -$1.2 million in Q3 2025 per TNXP's latest filing, from -$2.1 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $7.0 million in Q1 2024 and bottomed at -$2.1 million in Q1 2025.
• The 3-year median for Other Non Operating Income is $172000.0 (2023), against an average of $607222.2.
• Biggest YoY gain for Other Non Operating Income was 8357.14% in 2024; the steepest drop was 193.81% in 2024.
• Year by year, Other Non Operating Income stood at $7000.0 in 2023, then jumped by 8357.14% to $592000.0 in 2024, then plunged by 295.27% to -$1.2 million in 2025.
• Per Business Quant, the three latest TNXP Other Non Operating Income figures stand at -$1.2 million (Q3 2025), -$2.1 million (Q1 2025), and $592000.0 (Q4 2024).